Testing a Lung Cancer Screening Decision Aid
This study aims to create and test a helpful video and educational materials about lung cancer screening for patients in the Harris Health System. We want to make sure these materials are easy to understand for everyone, including those with low health literacy, and are available in both English and Spanish. We'll be asking healthcare providers about their current screening practices, and talking with patients in focus groups and interviews to understand what information they need. Participants will watch either the new lung cancer screening decision aid video or a colon cancer screening video, and answer surveys before and after to see how well the new materials help with decision-making. We're looking for 360 participants between 50 and 80 years old who currently smoke or quit less than 15 years ago, speak English or Spanish, and have no history of lung cancer.
- Study design
- This is an interventional study with an unclear status, planning to enroll 360 participants. It involves surveys, focus groups, cognitive interviews, and watching either a lung cancer screening decision aid video or a control video.
- What's involved
- Participants will take surveys before and after watching a video, and some may participate in focus groups or cognitive interviews. The study completion is expected to average 1 year.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed through study completion, which is expected to average 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Robert Vok, PHD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Safety and Adverse Events (AEs).Through study completion; an average of 1 year
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0